首页> 外国专利> Compounds for use in the prevention or treatment of gastrointestinal infections/inflammation in infants or young children

Compounds for use in the prevention or treatment of gastrointestinal infections/inflammation in infants or young children

机译:用于预防或治疗婴幼儿胃肠道感染/炎症的化合物

摘要

Food composition comprising only 2'-Fucosyllactose (2-FL) as fucosylated oligosaccharide and only lacto-N-neotetraose (LNnT) as N-acetylated oligosaccharide,where the ratio of fucosylated oligosaccharide(s):N-acetylated oligosaccharide(s) is 1,5:1 to 2,5:1,where the fucosylated oligosaccharide is present in an aggregate quantity of 0,8-1,5 g/L of the composition and/or in an aggregate quantity of 0,55-1,05 g/100 g of the dry weight composition; andwhere the N-acetylated oligosaccharide is present in the total quantity of 0,5-0,8 g/L of the composition and/or in the total quantity of 0,35-0,56 g/100g of the dry weight composition,for use in the prevention and/or treatment of gastrointestinal infections and/or gastrointestinal inflammation in infants or young children.
机译:仅包含2'-岩藻糖基乳糖(2-FL)作为岩藻糖基化寡糖,仅包含乳酸-N-新四糖(LNnT)作为N-乙酰化寡糖的食品组合物,其中岩藻糖基化寡糖与N-乙酰化寡糖之比为1,5:1至2,5:1,其中岩藻糖基化寡糖以所述组合物的总量为0.8-1.5g / L和/或以干重组合物的总量为0.55-1.05g / g存在;和其中N-乙酰化低聚糖以组合物的0.5-0.8g / L的总量和/或干重组合物的0.35-0.56g / 100g的总量存在,用于预防和/或治疗婴儿或幼儿的胃肠道感染和/或胃肠道炎症。

著录项

  • 公开/公告号DE202016008919U1

    专利类型

  • 公开/公告日2020-10-15

    原文格式PDF

  • 申请/专利权人 SOCIÉTÉ DES PRODUITS NESTLÉ S.A.;

    申请/专利号DE202016008919U1

  • 发明设计人

    申请日2016-03-04

  • 分类号A61K31/702;A61K45/06;A61P1;A61P1/04;A61P29;A61P31;A23L33/10;A23L33/125;A23L33/135;

  • 国家 DE

  • 入库时间 2022-08-21 11:01:07

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号